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The primary structure of a region on hormone-sensitive lipase was determined to be: Lys-Thr-Glu-Pro-Met-Arg-Arg-Ser- 
Val-Ser-Glu-Ala-Ala-Leu-Thr-Gln-Pro-Glu-Gly-Pro-Leu-Gly-Thr-Asp-Ser-Leu-Lys. Ser-8 was the only residue in the in- 
tact protein phosphorylated by cyclic AMP-dependent protein kinase. However, Set-10 also appeared to be present in 
a phosphorylated form, suggesting that it is a target for a distinct protein kinase in vivo. 
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1. INTRODUCTION 
Hormone-sensitive lipase (HSL) catalyses the 
rate-limiting step in adipose tissue lipolysis and its 
activity is under acute hormonal and neuronal con- 
trol [1]. Noradrenalin, released from sympathetic 
nerve endings, and circulating adrenalin, cor- 
ticotropin and glucagon, all stimulate lipolysis by 
raising the intracellular concentration of cyclic 
AMP. This leads to phosphorylation of HSL, 
causing activation of the enzyme and subsequent 
lipolysis [2]. The major anti-lipolytic hormone is 
insulin which reduces phosphorylation of HSL [2], 
and acts, at least in part, by lowering the level of  
cyclic AMP [3]. 
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Peptide mapping studies have suggested that 
HSL is phosphorylated at one site in vitro by cyclic 
AMP-dependent protein kinase [4]. This site is also 
that which is phosphorylated in isolated adipocytes 
in response to noradrenalin, consistent with the 
conclusion that this hormone acts via activation of 
cyclic AMP-dependent protein kinase [5]. A 
second site on HSL is also phosphorylated in the 
absence of lipolytic hormones. However, the ex- 
tent of  phosphorylation of this site does not 
change in the presence of lipolytic hormones [5] 
and its phosphorylation does not apparently have 
a direct effect on the activity of HSL [6]. 
Here, we report the primary structure of a 
region surrounding the serine residue phos- 
phorylated in vitro by cyclic AMP-dependent pro- 
tein kinase. 
2. MATERIALS AND METHODS 
2.1. Materials 
HSL was purified from bovine perirenal adipose tissue, 
essentially as in [7], except that the final chromatography on 
heparin-Sepharose wasomitted. The catalytic subunit of cyclic 
AMP-dependent protein kinase was purified to homogeneity 
from bovine heart or bovine adipose tissue [8]. [7)2p]ATP was 
from Amersham International, thermolysin a d trypsin (treated 
with diphenyl carbamyl chloride) from Sigma, and 
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Staphylococcus aureus V8 proteinase from Boehringer. N-Lys- 
specific proteinase from the fungus Armillaria mellea was pro- 
vided by Dr S. Doonan (University of Cork, Eire). The non- 
ionic detergent C13E~2 was from Berol Kemi (Sweden). 
2.2. Phosphorylation of HSL 
Prior to phosphorylation, HSL (approx. 15°70 pure) was 
dialysed against 5 mM imidazole-HC1, pH 7.0, containing 
50 mM NaC1, 0.2% (w/v) C13E12, 30% (w/v) glycerol, 1 mM 
dithiothreitol, 0.1 mM benzamidine, 5 mg/1 leupeptin and 
1 mg/l pepstatin and then concentrated to approx. 5 mg/ml us- 
ing an Amicon Centricon 30 centrifugal microconcentrator. 
Phosphorylation was carried out at 37°C for 15 min in the 
presence of 0.15 mM [y-32p]ATP (400-1000dpm/pmol), 
1 mM MgCI2 and 3/zM catalytic subunit of cyclic AMP- 
dependent protein kinase. The reaction was terminated by addi- 
tion of an equal volume of 0.3 M Tris-HCI (pH 6.8) containing 
25~0 (v/v) glycerol, 5% (w/v) SDS, 5o7o (v/v) 2-mercapto- 
ethanol and 0.0025o7e (w/v) bromophenol blue, followed by 
heating at 100°C for 5 min. 
2.3. Isolation and digestion of phosphorylated HSL 
Phosphorylated HSL was isolated by preparative SDS- 
polyacrylamide g l electrophoresis [9]. Following staining with 
Coomassie blue and destaining, the 84 kDa HSL polypeptide 
was excised from the gel and the protein eluted and precipitated 
with 20% (w/v) trichloroacetic acid, using 20/~g/ml 
fragmented DNA as carrier [10]. After centrifugation, the pro- 
tein pellets were washed three times with ether/ethanol (3:1) 
and resuspended in 0.2 ml of 0.5% (w/v) NI-I4HCO3. 
32p-HSL (3 nmol) was digested with trypsin (20/~g/ml) for 
1 h at 37°C in the presence of 2 mM CaC12, the reaction being 
terminated by the addition of trypsin inhibitor to 30/zg/ml. 
Following digestion, insoluble material was removed by cen- 
trifugation and the pellet extracted twice with 0.1 ml water to 
increase the recovery of soluble phosphopeptide. 
HSL was also digested sequentially with V8 proteinase and N- 
Lys-specific proteinase. 32p-HSL (2 nmol) was first digested for 
5 h at 37°C with 1 mg/ml V8 proteinase, the reaction being ter- 
minated by heating for 2 min at 100°C. Insoluble material was 
removed by centrifugation and the pellet extracted with 0.2 ml 
of 0.5o70 (w/v) NH4HCO3. The resulting supernatants (0.4 ml) 
were then digested with 0.5/zg N-Lys-specific proteinase for 
15 h at 37°C, the reaction being terminated as described above. 
Digestion of HSL with thermolysin was carried out as 
described in [11]. 
2.4. Purification and analysis of HSL phosphopeptides 
The phosphopeptides generated by proteolytic digestion were 
dried in a vacuum concentrator, resuspended in 1.0 ml of 1.0 M 
acetic acid and subjected to gel filtration on Sephadex G-25 
Superfine (90 × 1.2 cm) equilibrated in the same solvent. After 
pooling and drying the radioactive fractions, further purifica- 
tion was achieved by reverse-phase HPLC on a Vydac 218TP54 
Cls column (Phase Separations Group, Hesperia, CA) using a 
Gilson HPLC system equipped with on-line ultraviolet detector 
and radioactivity monitor. The peptides were applied to the col- 
umn in 0.1% (v/v) TFA and eluted with a linear gradient from 
0 to 30°70 acetonitrile in 0.1°7o TFA, with an increase in 
acetonitrile concentration of 0.33% per min. Further purifica- 
tion was achieved either by rechromatography on the Vydac 
column equilibrated in 10 mM ammonium acetate, pH 6.5, and 
eluted with a gradient of 0-30% acetonitrile, or by 
rechromatography in 0.1% TFA after incubating the peptide 
with ethanethiol in NaOH to convert phosphoserine residues to 
S-ethylcysteine [12]. S-Ethylcysteinyl peptides are eluted at 
higher acetonitrile concentrations than the phosphopeptides 
from which they were derived, and therefore resolved from im- 
purities [13]. 
Amino acid analysis was carried out using a Waters Picotag 
system and sequencer analysis on an Applied Biosystems 470A 
sequencer equipped for on-line Pth-amino acid analysis. The 
method of Wang et al. [14] was used to identify residues to 
which [32p]phosphate was attached, except hat thin layer elec- 
trophoresis rather than HPLC was used to separate inorganic 
[32p]phosphate from 32p-peptides. 
3. RESULTS 
Tryptic digestion solubilised 70-80~/0 of the 32p 
radioactivity associated with HSL. Approx. 80°10 
of this radioactivity was eluted as a single peak 
from Sephadex G-25 (Kay = 0.13, not shown) and 
reverse-phase HPLC (fig. 1A). The tryptic peptide 
(T1) was pure, and its N-terminal sequence is given 
in table 1. All of the 32p radioactivity associated 
with the peptide was released as inorganic 
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Fig. 1. Separation of tryptic and thermolytic phosphopeptides 
on a Vydac C18 column. Phosphopeptides from Sephadex G-25 
were chromatographed on a Vydac C~s column equilibrated in
0.1°70 (v/v) TFA as described in section 2. The elution profile 
of a tryptic digest is shown in panel A, and that of a thermolytic 
digest in panel B. 32p radioactivity is denoted by the full line 
and the acetonitrile gradient by the broken line. No 
radioactivity was eluted after 90 min. 
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phosphate after one cycle of Edman degradation, 
demonstrating that the N-terminal serine was the 
residue phosphorylated in the intact protein by 
cyclic AMP-dependent protein kinase. 
Although the tryptic phosphopeptide allowed 
determination of the primary structure on the car- 
boxyl side of the phosphoserine, it is known that 
the important recognition feature for cyclic AMP- 
dependent protein kinase is the presence of basic 
residues on the amino-terminal side of the 
phosphorylated residue [15]. Therefore, different 
digestion conditions were employed to obtain this 
additional information. Digestion of HSL with 
thermolysin solubilized 80-90070 of the 32p 
radioactivity associated with HSL, and this 
radioactivity was eluted as a major peak from 
Sephadex G-25 (Kay = 0.27, not shown) or reverse- 
phase HPLC in the presence of TFA (fig. 1B). This 
thermolytic peptide, termed Thl, after further 
purification by reverse-phase HPLC at pH 6.5, had 
the composition Ser0.9, Arg2.0, Meto.7, and its N- 
terminal sequence was Met-Arg-Arg (table 1). This 
suggested that Thl had the structure Met-Arg-Arg- 
Ser(P), and the complete absence of valine in the 
composition indicated that it was generated by 
Table 1 
Quantitation of gas-phase sequencer analyses 
T 1 Th 1 VL 1 T2(S-Et-C) 
Amino pmol Amino pmol Amino pmol Amino pmol 
acid acid acid acid 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
S 63 
V 31 
S 16 
E 22 
A 19 
A 18 
L 4 
T 2 
Q 2 
P 3 
E 2 
M 70 
R 30 
R 26 
K 28 S 90 
T 13 V 85 
E 51 S-Et-C 48 
P 54 E 70 
M 31 A 60 
R 6 A 53 
R 7 L 65 
S 30 T 9 
V 17 Q 13 
S 20 P 30 
E 3 E 18 
G 17 
P 14 
L 16 
G 10 
T 1 
D 3 
S 4 
L 5 
K 1 
cleavage of the phosphoseryl-valine bond in the 
tryptic peptide (table 1). These results were con- 
firmed by digestion of a different HSL preparation 
with a combination of V8 proteinase and N-Lys- 
specific proteinase. The phosphopeptide generated 
in this way was eluted from Sephadex G-25 as a 
major peak (Kav = 0.26). However, following 
reverse-phase HPLC in the presence of TFA, two 
major radioactive peaks, VL1 and VL2, were ob- 
tained (fig.2B). When these peptides were 
rechromatographed on the Vydac Cla column, 
phosphopeptide VL1 yielded a single radioactive 
peak, while VL2 was resolved into two major 
peaks, termed VL2a and VL2b, the former co- 
migrating with VL1. The sequences of VL1, VL2a 
and VL2b were identical (quantitation for VL1 
only is shown on table 1). This information con- 
firmed that the sequence of the thermolytic peptide 
was Met-Arg-Arg-Ser, and extended the sequence 
N-terminal to the phosphoserine by four residues. 
A further preparation of HSL when digested 
with trypsin yielded two peaks of 32p radioactivity 
on reverse-phase HPLC in the presence of TFA 
(fig.2A). One of these comigrated with peptide T1 
(fig.lA), while the second, termed T2, was eluted 
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Fig.2. Separation of phosphopeptidcs by reverse-phase HPLC. 
Phosphopeptides generated by digestion of a different 
preparation of HSL with trypsin (A), or a combination of V8 
proteinasc and N-Lys-specific proteinasc (B), were 
chromatographed on a Vydac C~s column as in rigA. 
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at a slightly higher acetonitrile concentration. All 
of the 32p radioactivity associated with T2 was 
released as inorganic phosphate after one cycle of 
Edman degradation, demonstrating that, as for 
T1, the N-terminal serine was the only residue 
phosphorylated by cyclic AMP-dependent protein 
kinase. In order to purify T2, this peptide was 
treated with ethanethiol in NaOH to convert 
phosphoserine to S-ethylcysteine, and rechromato- 
graphed on the Vydac C~s column under the same 
conditions. The pool of derivatised peptide was 
eluted 5-15 min later than before, and was 
therefore obtained in pure form. Sequencer ana- 
lysis yielded the complete structure of T2 (table 1), 
and its N-terminal sequence was identical to that of 
T1 (table 1). 
The analysis of T1, T2 and Thl had established 
that the N-terminal serine of the tryptic peptide 
was the only residue in the intact protein 
phosphorylated bycyclic AMP-dependent protein 
kinase. It was therefore initially surprising to find 
that the serine at position 3 of T2, and not the N- 
terminal serine, was the residue converted to S- 
ethylcysteine (table 1). However, Meyer et al. [16] 
have reported that N-terminal (or C-terminal) 
phosphoserine residues do not convert to S- 
ethylcysteine following incubation with ethanethi- 
ol in NaOH. The presence of S-ethylcysteine at 
position 3 implies that this residue is esterified 
(presumably tophosphate) in the purified peptide. 
Since this phosphoserine is not 32p-labelled, it 
would appear to represent an in vivo site of phos- 
phorylation, presumably introduced by an enzyme 
distinct from cyclic AMP-dependent protein 
kinase. 
Since peptides containing two phosphate groups 
are eluted from reverse-phase HPLC at lower 
acetonitrile concentrations than monophos- 
phorylated erivatives [17], T1 and VL1 may 
represent peptides phosphorylated at both serines, 
while peptides T2 and VL2 may be monophos- 
phorylated species containing phosphoserine at 
either position. The reason why peptide VL2 is 
resolved into two peaks by rechromatography at 
pH 6.5 is unclear, although partial oxidation of the 
methionine residue could underlie this ob- 
servation. 
4. DISCUSSION 
From the sequences given in table 1 the primary 
structure of a 27-residue region of the HSL 
polypeptide containing the serine residue 
phosphorylated by cyclic AMP-dependent protein 
kinase, can be deduced. The sequence, 
KTEPMRRS(P)VSEAALTQPEGPLGTDSLK, is 
consistent with the known specificity of this pro- 
tein kinase, in that two adjacent basic residues are 
present on the amino-terminal side of the 
phosphorylated serine [15]. The lack of an in- 
tervening residue between the phosphoserine and 
the two arginine residues is unusual, but occurs in 
cardiac troponin-I [18]. The very small acidic pep- 
tide that is generated by digestion with a combina- 
tion of trypsin and V8 proteinase [4] is likely to 
comprise residues 8-11. 
The sequence given here is the first reported ata 
on the primary structure of HSL and may be 
valuable for the production of anti-peptide an- 
tibodies and for initiating eDNA cloning. It will 
also be of interest to investigate whether the second 
phosphorylation site that has been identified in this 
region corresponds to the serine residue that is 
phosphorylated in vivo, but which is unaffected by 
hormonal stimulation (see section 2). 
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